HomeIGMS • NASDAQ
add
IGM Biosciences Inc
Previous close
$8.49
Day range
$8.00 - $8.49
Year range
$3.81 - $17.70
Market cap
477.50M USD
Avg Volume
396.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 497.00K | -4.79% |
Operating expense | 54.35M | -14.94% |
Net income | -49.82M | 16.01% |
Net profit margin | -10.02K | 11.78% |
Earnings per share | -0.83 | 37.59% |
EBITDA | -51.68M | 16.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 293.77M | -21.33% |
Total assets | 376.13M | -18.72% |
Total liabilities | 214.88M | -3.78% |
Total equity | 161.25M | — |
Shares outstanding | 59.02M | — |
Price to book | 3.10 | — |
Return on assets | -33.68% | — |
Return on capital | -60.39% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -49.82M | 16.01% |
Cash from operations | -42.42M | 16.82% |
Cash from investing | 8.65M | -87.61% |
Cash from financing | 152.00K | 102.67% |
Net change in cash | -33.61M | -277.83% |
Free cash flow | -30.46M | 6.57% |
About
Founded
1993
Website
Employees
216